Zhu Jian-Hua, Wang Wen-Qiong, Tang Le, Sun Yi-Rei, Yu Rong-Min
College of Pharmacy, Jinan University, Guangzhou 510632, China.
Zhong Yao Cai. 2009 May;32(5):670-3.
To provide theoretical basis for the production of ginsenosides by using modern biotechnologies, the comparative studies of the amount of ginsenosides between the crown galls and Chinese medicinal materials of Panax quinquefolium were carried out.
Total ginsenosides were determined by spectrophotometry, and the contents of ginsenoside Rb1, Rb3, Rc, Re were determined by HPLC.
(1) The total ginsenosides in the crown galls of Panax quinquefolium (aftert 27 days' cultivation) was almost as much as that of Chinese medicinal material of Panax quinquefolium. (2) The contents of ginsenoside Rb1, Re in the crown galls were about half of that in Chinese medicinal materials of Panax quinquefolium, and ginsenoside Rc was about 80%. But the amount of ginsenoside Rb3 in the crown galls of Panax quinquefolium was much more than that in Chinese medicinal materials of Panax quinquefolium as almost 15 times higher.
The crown galls of Panax quinquefolium may be a new potential resource for large-scale production of ginsenosides.
为利用现代生物技术生产人参皂苷提供理论依据,对西洋参冠瘿与西洋参中药材中人参皂苷的含量进行比较研究。
采用分光光度法测定总人参皂苷含量,采用高效液相色谱法测定人参皂苷Rb1、Rb3、Rc、Re的含量。
(1)西洋参冠瘿(培养27天后)中的总人参皂苷含量几乎与西洋参中药材中的总人参皂苷含量相当。(2)冠瘿中人参皂苷Rb1、Re的含量约为西洋参中药材中含量的一半,人参皂苷Rc的含量约为80%。但西洋参冠瘿中人参皂苷Rb3的含量远高于西洋参中药材中的含量,几乎高出15倍。
西洋参冠瘿可能是大规模生产人参皂苷的一种新的潜在资源。